Close Menu

NEW YORK – With the coronavirus pandemic showing no signs of abating, test makers have been put on the front lines of finding out who has the disease so that clinicians can care for them, contain spread of the SARS-CoV-2 virus, and protect public health.

Tracking, validating, and evaluating tests is increasingly important, as desperate governments try to quickly procure and scale up diagnostic testing under tremendous time pressures.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.